Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

933 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM. Rossi JF, et al. Among authors: johnson sa. J Clin Oncol. 2004 Apr 1;22(7):1260-7. doi: 10.1200/JCO.2004.05.012. J Clin Oncol. 2004. PMID: 15051774 Clinical Trial.
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA. Foran JM, et al. Among authors: johnson sa. J Clin Oncol. 1999 Feb;17(2):546-53. doi: 10.1200/JCO.1999.17.2.546. J Clin Oncol. 1999. PMID: 10080598 Clinical Trial.
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
Crawley CR, Foran JM, Gupta RK, Rohatiner AZ, Summers K, Matthews J, Micallef IN, Radford JA, Johnson SA, Johnson PW, Sweetenham JW, Lister TA. Crawley CR, et al. Among authors: johnson pw, johnson sa. Ann Oncol. 2000 Jul;11(7):861-5. doi: 10.1023/a:1008381105849. Ann Oncol. 2000. PMID: 10997815 Free article. Clinical Trial.
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
Jackson G, Taylor P, Smith GM, Marcus R, Smith A, Chu P, Littlewood TJ, Duncombe A, Hutchinson M, Mehta AB, Johnson SA, Carey P, MacKie MJ, Ganly PS, Turner GE, Deane M, Schey S, Brookes J, Tollerfield SM, Wilson MP. Jackson G, et al. Among authors: johnson sa. Br J Haematol. 2001 Jan;112(1):127-37. doi: 10.1046/j.1365-2141.2001.02551.x. Br J Haematol. 2001. PMID: 11167793 Free article. Clinical Trial.
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V, Johnson S, Chevret S, Copplestone A, Rule S, Tournilhac O, Seymour JF, Patmore RD, Wright D, Morel P, Dilhuydy MS, Willoughby S, Dartigeas C, Malphettes M, Royer B, Ewings M, Pratt G, Lejeune J, Nguyen-Khac F, Choquet S, Owen RG. Leblond V, et al. J Clin Oncol. 2013 Jan 20;31(3):301-7. doi: 10.1200/JCO.2012.44.7920. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233721 Clinical Trial.
Letter: Survival in acute myeloid leukaemia.
Johnson SA, Beard ME, Lister TA, Wrigley PF, Whitehouse JM. Johnson SA, et al. Lancet. 1975 Dec 20;2(7947):1254-5. doi: 10.1016/s0140-6736(75)92088-7. Lancet. 1975. PMID: 53737 No abstract available.
933 results